Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
NCT00284258
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
426
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
CPT-11 and TS-1
DRUG:
CPT-11, 5-FU and l-LV
Sponsor
Taiho Pharmaceutical Co., Ltd.
Collaborators
[object Object]